Niagen Bioscience (NAGE) Inventory (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Inventory data on file, last reported at $24.0 million in Q1 2026.

• Inventory for Q1 2026 came in at $24.0 million, up 114.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.0 million (up 114.72% YoY), and the FY2025 annual result was $20.4 million, up 122.19% from the prior year.
• Inventory advanced to $24.0 million in Q1 2026 per NAGE's latest filing, from $20.4 million in the prior quarter.
• Over five years, Inventory peaked at $24.0 million in Q1 2026 and troughed at $9.2 million in Q4 2024.
• A 5-year average of $14.4 million and a median of $14.4 million in 2025 frame the typical range for Inventory.
• The sharpest annual moves came in 2024 and 2025: Inventory sank 36.72% in 2024, then soared 122.19% in 2025.
• A 5-year view of Inventory shows it stood at $14.7 million in 2022, then declined by 1.04% to $14.5 million in 2023, then slumped by 36.72% to $9.2 million in 2024, then surged by 122.19% to $20.4 million in 2025, then grew by 17.59% to $24.0 million in 2026.
• Business Quant data shows NAGE's Inventory at $24.0 million in Q1 2026, $20.4 million in Q4 2025, and $18.8 million in Q3 2025.